These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17403130)

  • 1. Activity of telithromycin and comparators against isolates of Legionella pneumophila collected from patients with community-acquired respiratory tract infections: PROTEKT Years 1-5.
    Dunbar LM; Farrell DJ
    Clin Microbiol Infect; 2007 Jul; 13(7):743-6. PubMed ID: 17403130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
    Reinert RR; Rodloff AC; Halle E; Baer W; Beyreiss B; Seifert H; Wichelhaus TA; Maass M; Mehl M
    Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of Legionella pneumophila from clinical & environmental sources in a tertiary care hospital.
    Anbumani S; Gururajkumar A; Chaudhury A
    Indian J Med Res; 2010 Jun; 131():761-4. PubMed ID: 20571163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).
    Kohno S; Hoban D;
    J Chemother; 2003 Aug; 15(4):335-41. PubMed ID: 12962361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).
    Felmingham D; Farrell DJ; Reinert RR; Morrissey I
    J Infect; 2004 Jan; 48(1):39-55. PubMed ID: 14667791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Legionella pneumophila serogroup 1].
    Sabrià M
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):391-3. PubMed ID: 14525702
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia by Legionella pneumophila serogroups 1-6 in Brazil.
    Chedid MB; Ilha Dde O; Chedid MF; Dalcin PR; Buzzetti M; Jaconi Saraiva P; Griza D; Menna Barreto SS
    Respir Med; 2005 Aug; 99(8):966-75. PubMed ID: 15950137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
    Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
    J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Community-acquired Legionella pneumonia : data from the CAPNETZ study].
    von Baum H; Lück C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jun; 54(6):688-92. PubMed ID: 21626372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legionnaires' Disease in South Africa, 2012-2014.
    Wolter N; Carrim M; Cohen C; Tempia S; Walaza S; Sahr P; de Gouveia L; Treurnicht F; Hellferscee O; Cohen AL; Benitez AJ; Dawood H; Variava E; Winchell JM; von Gottberg A
    Emerg Infect Dis; 2016 Jan; 22(1):131-3. PubMed ID: 26692504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].
    Benito JR; Montejo JM; Cancelo L; Zalacaín R; López L; Fernández Gil de Pareja J; Alonso E; Oñate J
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):394-400. PubMed ID: 14525703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
    Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
    Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
    J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal community-acquired pneumonia caused by Legionella pneumophila and fluoroquinolone-resistant Salmonella enterica serotype Choleraesuis bacteraemia.
    Jean SS; Tsai MH; Chen WC; Ho SJ; Wu MH; Hsueh PR
    Int J Antimicrob Agents; 2009 Feb; 33(2):189-90. PubMed ID: 18993035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
    Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
    Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophila.
    Carbon C; Nusrat R
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):650-2. PubMed ID: 15322940
    [No Abstract]   [Full Text] [Related]  

  • 20. Legionnaires disease--reordered.
    Buchholz U; Stöcker P; Brodhun B
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):104-5. PubMed ID: 19968492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.